Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2019

Publisher Name :
Date: 15-Jan-2019
No. of pages: 60
Delivery of the Report will take 2-3 working days once order is placed.

"Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

- Clinical

- Non-clinical

- Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for "Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for "Angiotensin Converting Enzyme (ACE) Inhibitor

The report assesses the active Angiotensin Converting Enzyme (ACE) Inhibitor pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.

Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

- Provides a snapshot of the therapeutics pipeline activity for "Angiotensin Converting Enzyme (ACE) Inhibitor

- Features the Angiotensin Converting Enzyme (ACE) Inhibitor pipeline across the complete product development cycle including all clinical and non-clinical stages

- Offers detailed therapeutic product profiles of Angiotensin Converting Enzyme (ACE) Inhibitor with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

- Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

- Coverage of dormant and discontinued pipeline projects across "Angiotensin Converting Enzyme (ACE) Inhibitor

Reasons to Buy

- Establish a comprehensive understanding of the current pipeline scenario across Angiotensin Converting Enzyme (ACE) Inhibitor to formulate effective R&D strategies

- Assess challenges and opportunities that influence Angiotensin Converting Enzyme (ACE) Inhibitor research & development (R&D)

- Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

- Identify and understand the sought after therapy areas and indications for "Angiotensin Converting Enzyme (ACE) Inhibitor

- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

- Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Angiotensin Converting Enzyme (ACE) Inhibitor to enhance and expand business potential and scope

- Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

- Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2019

Table of Contents

1. Report Introduction
2. Angiotensin Converting Enzyme (ACE) Inhibitor - Overview
3. Pipeline Therapeutics
An Overview of Pipeline Products for Angiotensin Converting Enzyme (ACE) Inhibitor
4. Comparative Analysis
5. Angiotensin Converting Enzyme (ACE) Inhibitor Pipeline Products in Clinical Stages
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Other product profiles in the detailed report…..
6. Angiotensin Converting Enzyme (ACE) Inhibitor Pipeline Products in Non-clinical Stages
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Other product profiles in the detailed report…..
7. Therapeutic Assessment: Active Products
Pipeline Assessment by Route of Administration
Pipeline Assessment by Stage and Route of Administration
Pipeline Assessment by Molecule Type
Pipeline Assessment by Stage and Molecule Type
8. Inactive Pipeline Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Reason for dormancy/discontinuation
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1: Total Pipeline Products for Angiotensin Converting Enzyme (ACE) Inhibitor
Table 2: Angiotensin Converting Enzyme (ACE) Inhibitor Therapeutic Products in Clinical Stages
Table 3: Angiotensin Converting Enzyme (ACE) Inhibitor Therapeutic Products in Non-clinical Stages
Table 4: Pipeline Assessment by Route of Administration
Table 5: Pipeline Assessment by Stage and Route of Administration
Table 6: Pipeline Assessment by Molecule Type
Table 7: Pipeline Assessment by Stage and Molecule Type
Table 8: Discontinued Products
Table 9: Dormant Products

List of Figures

Figure 1: Total Products for Angiotensin Converting Enzyme (ACE) Inhibitor
Figure 2: Angiotensin Converting Enzyme (ACE) Inhibitor Therapeutic Products in Clinical Stages
Figure 3: Angiotensin Converting Enzyme (ACE) Inhibitor Therapeutic Products in Non-clinical Stages
Figure 4: Pipeline Analysis by Route of Administration
Figure 5: Pipeline Analysis by Stage and Route of Administration
Figure 6: Pipeline Analysis by Molecule Type
Figure 7: Pipeline Analysis by Stage and Molecule Type
Figure 8: Discontinued Products
Figure 9: Dormant Products
  • Global Tyrosine Kinase JAK Inhibitors Market Research Report 2020 (Covid-19 Version)
    Published: 31-May-2020        Price: US 3500 Onwards        Pages: 114
    Summary Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - To......
  • Mitogen Activated Protein Kinase 8 Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 29-May-2020        Price: US 2280 Onwards        Pages: 54
    Summary According to 99Strategy, the Global Mitogen Activated Protein Kinase 8 Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Mitogen Activated Protein Kinase 8 market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environm......
  • COVID-19 Impact on a-Amylase Market, Global Research Reports 2020-2021
    Published: 29-May-2020        Price: US 3250 Onwards        Pages: 94
    This report covers market size and forecasts of a-Amylase, including the following market information: Global a-Amylase Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT) Global a-Amylase Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT) Global a-Amylase Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT) ......
  • Global Superoxide Dismutase Market Research Report 2020 (Covid-19 Version)
    Published: 29-May-2020        Price: US 3500 Onwards        Pages: 133
    Summary Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South America - Middle East & Africa By Type - Cu.Zn—SOD - Mn—SOD - Fe—SOD By Application - Food - Chemical Industry - Others By Company - Ionis Pharmaceuticals - Neurimmune Holding AG - ProMIS Neurosciences - RXi Pharmaceuticals Corporation......
  • Reverse Transcriptase Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 100
    Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA. This report contains market size and forecasts of Reverse Transcriptase in US, including th......
  • Lysozyme Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 94
    Lysozyme is an enzyme that plays an important role in the prevention of bacterial infections. Lysozyme is an enzyme used to break down bacterial cell walls to improve protein or nucleic acid extraction efficiency. Lysozymes (muramidases) are a family of enzymes with antimicrobial activity characterized by the ability to damage the cell wall of bacteria. The enzyme acts by catalyzing the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidogly......
  • Alcohol Dehydrogenase Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
    Published: 28-May-2020        Price: US 2700 Onwards        Pages: 91
    Alcohol dehydrogenase (ADH), part of the oxidoreductase family, catalyzes the oxidation of alcohols, using NAD+ or NADP+ as the electron acceptor (White and White 1997). The reaction is reversible and substrates can be a variety of primary or secondary alcohols, and hemiacetals. Alcohol dehydrogenases are present in most organisms. This report contains market size and forecasts of Alcohol Dehydrogenase in US, including the following market information: US Alcohol Dehydrogen......
  • 2015-2027 Global mTOR Inhibitors Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 26-May-2020        Price: US 2960 Onwards        Pages: 106
    The worldwide market for mTOR Inhibitors is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving fa......
  • 2015-2027 Global Lipase Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 26-May-2020        Price: US 2960 Onwards        Pages: 122
    The worldwide market for Lipase is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, re......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs